Retraction for Wei et al. Electroacupuncture stimulation at Yanglingquan acupoint ameliorates hepatic ischemia-reperfusion injury by down-regulating ET-1 to inhibit TAK1-JNK/p38 pathway.

RetractionRetraction for Wei et al. Electroacupuncture stimulation at Yanglingquan acupoint ameliorates hepatic ischemia-reperfusion injury by down-regulating ET-1 to inhibit TAK1-JNK/p38 pathway.Published Online:17 Nov 2021https://doi.org/10.1152/ajpgi.00012.2021_RETRetracted articleMoreSectionsPDF (99 KB)Download PDF ToolsExport citationAdd to favoritesGet permissionsTrack citations ShareShare onFacebookTwitterLinkedInEmail Wei L, Su Y, Tan S, Zou Y, Tang Y, Kong G, Chen W. Electroacupuncture stimulation at Yanglingquan acupoint ameliorates hepatic ischemia-reperfusion injury by down-regulating ET-1 to inhibit TAK1-JNK/p38 pathway. Am J Physiol Gastrointest Liver Physiol. First published August 4, 2021; doi:10.1152/ajpgi.00012.2021.The American Physiological Society is retracting the Articles in Press version of this article. Confidence in the work has been lost due to the failure of authors to communicate with the editorial office regarding their proofs.This article has no references to display. Previous Back to Top FiguresReferencesRelatedInformationRelated articlesElectroacupuncture stimulation at Yanglingquan acupoint ameliorates hepatic ischemia-reperfusion injury by down-regulating ET-1 to inhibit TAK1-JNK/p38 pathway 04 Aug 2021American Journal of Physiology-Gastrointestinal and Liver Physiology More from this issue > Video Abstract Volume 321Issue 6December 2021Pages G690-G690 Crossmark Copyright & PermissionsCopyright © 2021 the American Physiological Society.https://doi.org/10.1152/ajpgi.00012.2021_RETPubMed34788160History Published online 17 November 2021 Published in print 1 December 2021 Metrics Downloaded 162 times